05/12/2025 RCI Banque discloses updated binding MREL (1) requirement RCI Banque has received the draft of the decision of the Single Resolution Board (SRB) on its minimum requirement for own funds and eligible liabilities (MREL (1)). The requirement was repealed in 2024 for entities whose resolution plan is “liquidation,” which was and still is the case for RCI Banque SA. The SRB may, however, decide on an exceptional basis to impose a MREL requirement on these entities. The new requirement has been set a ...

Core Points - AS PRFoods' subsidiary Saaremere Kala AS has signed an agreement to sell its 100% shareholding in Saare Kala Tootmine OÜ to Latvian company Brīvais Vilnis A/S, requiring shareholder approval for completion [1][5][31] - The transaction aligns with AS PRFoods' debt restructuring objectives, aiming to sell core assets within a three-year period to distribute proceeds among creditors [2] - The sale price for the shareholding is set at EUR 2,000,000, with additional claims from shareholder loans and an inventory loan also being transferred [11][20] Transaction Details - The sale is part of a broader strategy to manage debt and is facilitated by financial advisor Oaklins Estonia OÜ [2] - The transaction is not classified as a related party transaction, as the ultimate beneficiaries of the buyer have no interests in AS PRFoods [3] - The management board of AS PRFoods has no personal interests in the transaction, and Timo Pärn will remain on SKT's management board post-sale [4] Financial Implications - The transaction is expected to generate extraordinary income of EUR 211,900.77 for AS PRFoods in the financial year 2025/2026, despite an unconsolidated net loss of EUR 2,204,569.26 [13][14] - SKT has received intra-group loans totaling EUR 1,539,294.53, with accrued interest of EUR 117,024.62 as of December 4, 2025 [9][19] - An inventory loan of EUR 200,000 has also been granted to SKT, with potential for an additional EUR 100,000 [10][20] Preconditions and Approvals - The transaction requires approval from AS PRFoods' general meeting of shareholders, with voting to occur without a physical meeting [5][28] - Preconditions for the transfer include the fulfillment of certain conditions by January 31, 2026, or the right to withdraw from the agreement [6] - The sales agreement includes stipulations for the transfer of claims related to shareholder loans and inventory loans upon receipt of the sales price [7][12] Shareholder Information - The management board proposes several resolutions for shareholder approval, including the sale of SKT's shareholding and the approval of the annual report for the financial year [31][32] - The net profit for the period from July 1, 2024, to June 30, 2025, is reported at EUR 7,338,801.33, with plans for profit allocation [33] - Shareholders can cast their votes digitally or via paper ballots, with specific instructions provided for the voting process [29][30]

Aspo Plc ANNOUNCEMENT 5.12.2025 Aspo Plc: Share repurchase 5.12.2025 In the Helsinki Stock Exchange Trade date 5.12.2025 Bourse trade Buy Share ASPO Amount 3 000SharesAverage price/ share 6,6573EURTotal cost 19 971,90EUR Aspo Plc now holds a t ...

Core Points - A meeting of the creditors of AUGA group was held on December 3, 2025, to form a Creditors' Committee and define its functions [1] - The restructuring plan of the Company was approved, leading to the appointment of 5 members to the Creditors' Committee [1] Group 1: Creditors' Committee Composition - The Creditors' Committee includes two largest secured creditors, two representatives of other creditors' groups, and a representative of employees' interests [1] - Uždaroji akcinė bendrovė "Urbo bankas" was nominated as the third largest representative of other creditors' group after BIGBANK AS declined to participate [1] Group 2: Committee Members - The Chairperson of the Creditors' Committee is from Komanditinė ūkinė bendrija "Pagalbos verslui fondas" [2] - Laurynas Miškinis represents employees' interests [2] - Uždaroji akcinė bendrovė "Okseta" represents creditors whose claims are secured by pledge and/or mortgage [2] - Akciju sabiedriba "Citadele banka" Lietuvos filialas and Uždaroji akcinė bendrovė "Urbo bankas" represent other creditors' groups [2]

As announced by AUGA group, AB, legal entity code 126264360 undergoing restructuring, legal entity code 126264360 (hereinafter – the Company) in its material event notice dated 20 January 2025, its wholly controlled subsidiary UAB ‚ AWG investment 1’ (hereinafter – the Issuer) has issued private bonds, ISIN LT0000409104, with a total nominal value of EUR 4,984,000 (hereinafter – the Bonds). The Issuer undertook to redeem the Bonds and pay the accrued but unpaid interest by 8 November 2025. Since the redempt ...

ABSECON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Absecon Bancorp (the “Company”) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors declared a regular quarterly cash dividend in the amount of $1.05 per share, payable on December 30, 2025 to shareholders of record as of December 16, 2025. The First National Bank of Absecon, a nationally chartered bank headquartered in Absecon, New ...

CARLSBAD, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Aptera Motors (Nasdaq: SEV) announced today that Co-CEO Chris Anthony will participate in A.G.P.’s Annual Virtual Electric Vehicles and Transportation Conference on December 9, 2025. The event is hosted by A.G.P./Alliance Global Partners. A.G.P.’s Capital Markets team works closely with portfolio managers of hedge funds, mutual funds, and registered investment advisors. Chris Anthony will deliver an investor presentation as part of the conference program. ...

Copenhagen Airports A/S hereby announces that the company has today received the attached notice from the Kingdom of Denmark via the Ministry of Finance. The notice reminds the shareholders of Copenhagen Airports A/S that the offer period for the mandatory tender offer submitted by the Kingdom of Denmark, via the Ministry of Finance, expires on 10 December 2025 at 11:59 p.m. (CET). Attachments Company announcement reminding of the expiry of the offer period for the mandatory tender offer Reminder of m ...

Core Insights - Gelteq Limited has announced preclinical findings that demonstrate the effectiveness, flexibility, and safety of its proprietary gel-based oral delivery systems, addressing significant challenges in pharmaceutical development [1][6]. Preclinical Study Results - Two preclinical studies showed a 300% increase in bioavailability of an oil-soluble compound in Gelteq's gel base compared to an existing FDA-approved reference product within the first hour, which is critical for rapid onset of action [2]. - Overall absorption of the oil-soluble compound improved by more than 20% over 24 hours when using Gelteq's gel base compared to the reference product [3]. - The gel platform enables controlled movement through the digestive system, targeted release, and effective absorption while ensuring full clearance of both the active pharmaceutical ingredients and the gel material [4]. Mechanism of Action - The gel disperses the active ingredient uniformly along the small intestine, enhancing absorption through mucoadhesive interactions and presenting the drug across a larger intestinal surface area [5]. - The gel's structural matrix allows for efficient transit and rapid early absorption of the active pharmaceutical ingredient, reinforcing its safety and compatibility with oral administration [6]. Industry Context - Over 40% of approved drugs and up to 90% of developmental candidates face issues with poor solubility and bioavailability, leading to significant annual investments in new technologies to address these challenges [7]. - Gelteq's platform offers a streamlined solution that may reduce developmental burdens, enhance bioavailability, and potentially revive previously shelved or challenging molecules [7]. Therapeutic Applications - Therapeutic areas likely to benefit from Gelteq's gel-based delivery system include neurology, inflammation and pain management, hormonal therapies, cardiovascular medicine, nutraceuticals, weight management, oncology, and veterinary health, where lipid-based or poorly soluble APIs are common [8]. Strategic Positioning - By enabling consistent absorption, targeted delivery, reduced reliance on excipients, and strong safety characteristics, Gelteq positions itself as a valuable development partner for pharmaceutical and nutraceutical companies looking to reformulate existing assets or tackle complex formulation challenges [9].

Core Insights - Dangbei is offering significant discounts on its 4K home cinema and portable projectors during a limited-time promotion on Amazon.com, with savings of up to 47.4% and as much as $900 off selected models [3][12]. Product Offerings - The Dangbei DBOX02, a flagship 4K ALPD laser projector, is now priced at $999, down from $1,899, providing a 47.4% discount [6][7]. - The DBOX02 Pro, featuring a flexible gimbal stand, is available for $899, a 43.8% reduction from its original price of $1,599 [8]. - The MP1 Max, a 4K Hybrid Tri-Laser + LED projector, is now $1,399, reflecting a 30.0% discount from $1,999 [9]. - The Dangbei Atom, an ultra-slim laser projector, is priced at $549, down 38.9% from $899 [10]. - The portable Freedo projector is available for $349, a 36.4% discount from $549 [11]. - The compact N2 mini projector is now $149, down from $229, offering a 34.9% discount [12]. Promotional Period - The promotional offers are exclusively available on the Dangbei Store on Amazon.com from December 2 to December 15, 2025, targeting consumers looking for affordable home entertainment solutions during the holiday season [12]. Company Overview - Dangbei is recognized as a premium provider of smart entertainment solutions, specializing in home and portable projectors, with over 200 million users globally [13].